Genmab | Spese Operative



Operating Expenses Cambiamento Data
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Almirall EUR 485.13M 289.74M 2024-12
Amarin USD 67.47M 549K 2024-09
Amgen USD 6.86B 85M 2025-03
argenx SE USD 651.74M 16.37M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Bayer EUR 11.41B 3.22B 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Demant DKK 9B 4.47B 2024-12
Exelixis USD 368.59M 34.96M 2025-04
Fresenius Medical Care EUR 4.55B 275.89M 2025-03
Galapagos EUR 233.68M 95.46M 2025-03
Genmab DKK 527M 3.72B 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
GN Store Nord DKK 3.77B 547M 2025-03
GRIFOLS EUR 1.52B 87M 2025-03
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Insmed USD 340.96M 6.11M 2025-03
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.22B 52M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 1.23B 1.31B 2024-06



Genmab Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.